Pacira Pharmaceuticals reported $226.75M in Cash and Equivalent for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Acelrx Pharmaceuticals ACRX:US $ 21.82M 9.16M
Aerie Pharmaceuticals AERI:US $ 56.44M 19.25M
Amerisourcebergen ABC:US $ 2960.76M 208.12M
Astellas Pharma 4503:JP Y 315986M 34227M
Bristol Myers Squibb BMY:US $ 12369M 1610M
Cara Therapeutics CARA:US $ 21.36M 7.91M
Coherus Biosciences CHRS:US $ 325.68M 91.52M
Depomed DEPO:US $ 61.39M 24.58M
Endo International Ordinary Shares ENDP:US $ 1413.15M 94.05M
Heron Therapeutics HRTX:US $ 56.91M 33.63M
Horizon Pharma HZNP:US $ 1643.13M 62.81M
Ironwood Pharmaceuticals IRWD:US $ 593.37M 26.76M
Johnson & Johnson JNJ:US $ 1579M 322M
Lannett LCI:US $ 106.11M 7.47M
Ligand Pharmaceuticals LGND:US $ 14.99M 4.53M
Nektar Therapeutics NKTR:US $ 67.99M 42.78M
Omeros OMER:US $ 8.96M 91.84M
Pacira Pharmaceuticals PCRX:US $ 226.75M 358.83M
Perrigo Ordinary Shares PRGO:US $ 1965.5M 100.6M
Pfizer PFE:US $ 2470M 526M
Revance Therapeutics RVNC:US $ 198.36M 87.74M
Supernus Pharmaceuticals SUPN:US $ 115.72M 87.72M
Teva Pharmaceutical TEVA:IT 2.18B 10M
Xeris Pharmaceuticals Inc XERS:US $ 103.77M 36.5M
Zoetis ZTS:US $ 3132M 350M